News and Press - JDRF T1D Fund

Recent Press Releases

T1D Fund in the News

Provention Bio Announces Breakthrough Therapy Designation for Teplizumab (PRV-031) for the Prevention or Delay of Clinical Type 1 Diabetes in At-Risk Individuals

08/05/2019 | Cision PR Newswire

T1D Fund in the News

JDRF T1D Fund Named as Patients First Finalist in Xconomy 2019 Awards

07/10/2019 | Xconomy

T1D Fund in the News

Provention Bio shares more than triple on diabetes prevention study results

06/10/2019 | CNBC

T1D Fund in the News

Diasome’s Hepatocyte Directed Vesicle (HDV) Technology Met Primary Endpoint in Phase 2b Trial in Type 1 Diabetes

06/10/2019 | Globe Newswire

T1D Fund in the News

In Quest for Cures, Medical Nonprofits Seek to Wield Their Own Venture Funding Power

05/31/2019 | Wall Street Journal